189 related articles for article (PubMed ID: 37773310)
41. MR-based radiomics-clinical nomogram in epithelial ovarian tumor prognosis prediction: tumor body texture analysis across various acquisition protocols.
Wang T; Wang H; Wang Y; Liu X; Ling L; Zhang G; Yang G; Zhang H
J Ovarian Res; 2022 Jan; 15(1):6. PubMed ID: 35022079
[TBL] [Abstract][Full Text] [Related]
42. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
[TBL] [Abstract][Full Text] [Related]
43. Novel prognostic nomograms to assess survival in high-grade serous ovarian carcinoma after surgery and chemotherapy: a retrospective cohort study from SEER database.
Huang W; Bao Y; Luo X; Yao L; Yuan L
Ann Transl Med; 2022 Jul; 10(13):728. PubMed ID: 35957727
[TBL] [Abstract][Full Text] [Related]
44. Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors.
Zhu C; Ding J; Wang S; Qiu Q; Ji Y; Wang L
Thorac Cancer; 2021 Dec; 12(23):3110-3120. PubMed ID: 34647417
[TBL] [Abstract][Full Text] [Related]
45. Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients.
Buttarelli M; Ciucci A; Palluzzi F; Raspaglio G; Marchetti C; Perrone E; Minucci A; Giacò L; Fagotti A; Scambia G; Gallo D
J Exp Clin Cancer Res; 2022 Feb; 41(1):50. PubMed ID: 35120576
[TBL] [Abstract][Full Text] [Related]
46. Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis.
Beer L; Sahin H; Bateman NW; Blazic I; Vargas HA; Veeraraghavan H; Kirby J; Fevrier-Sullivan B; Freymann JB; Jaffe CC; Brenton J; Miccó M; Nougaret S; Darcy KM; Maxwell GL; Conrads TP; Huang E; Sala E
Eur Radiol; 2020 Aug; 30(8):4306-4316. PubMed ID: 32253542
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients.
Jiao M; Sun W; Li L; Li C; Zhou J; Li Q; Duan L
Front Genet; 2022; 13():878123. PubMed ID: 36246613
[No Abstract] [Full Text] [Related]
48. Construction and Validation of a Nomogram to Predict the Postoperative Venous Thromboembolism Risk in Patients with HGSOC.
Huang Z; Li L; Gong Z; Tang L
Clin Appl Thromb Hemost; 2024; 30():10760296241255958. PubMed ID: 38767088
[TBL] [Abstract][Full Text] [Related]
49. Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: A retrospective observational cohort study.
Hu D; Ma D; Zhang ZJ; Zhang Y; Huang K; Li X
Front Endocrinol (Lausanne); 2023; 14():1103429. PubMed ID: 36742399
[TBL] [Abstract][Full Text] [Related]
50. A Nomogram Combining MRI Multisequence Radiomics and Clinical Factors for Predicting Recurrence of High-Grade Serous Ovarian Carcinoma.
Li C; Wang H; Chen Y; Fang M; Zhu C; Gao Y; Li J; Dong J; Wu X
J Oncol; 2022; 2022():1716268. PubMed ID: 35571486
[TBL] [Abstract][Full Text] [Related]
51. Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer.
Han L; Zhu Y; Liu Z; Yu T; He C; Jiang W; Kan Y; Dong D; Tian J; Luo Y
Eur Radiol; 2019 Jul; 29(7):3820-3829. PubMed ID: 30701328
[TBL] [Abstract][Full Text] [Related]
52. Initial CT-based radiomics nomogram for predicting in-hospital mortality in patients with traumatic brain injury: a multicenter development and validation study.
Zheng RZ; Zhao ZJ; Yang XT; Jiang SW; Li YD; Li WJ; Li XH; Zhou Y; Gao CJ; Ma YB; Pan SM; Wang Y
Neurol Sci; 2022 Jul; 43(7):4363-4372. PubMed ID: 35199252
[TBL] [Abstract][Full Text] [Related]
53. Development and Validation of an Immune-Related Gene-Pair Model of High-Grade Serous Ovarian Cancer After Platinum-Based Chemotherapy.
Lin J; Xu X; Sun D; Li T
Front Oncol; 2020; 10():626555. PubMed ID: 33680950
[TBL] [Abstract][Full Text] [Related]
54. Preoperative computed tomography-guided disease-free survival prediction in gastric cancer: a multicenter radiomics study.
Wang S; Feng C; Dong D; Li H; Zhou J; Ye Y; Liu Z; Tian J; Wang Y
Med Phys; 2020 Oct; 47(10):4862-4871. PubMed ID: 32592224
[TBL] [Abstract][Full Text] [Related]
55. Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer.
Wang XX; Ding Y; Wang SW; Dong D; Li HL; Chen J; Hu H; Lu C; Tian J; Shan XH
Cancer Imaging; 2020 Nov; 20(1):83. PubMed ID: 33228815
[TBL] [Abstract][Full Text] [Related]
56. Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With
Tang X; Li Y; Yan WF; Qian WL; Pang T; Gong YL; Yang ZG
Front Oncol; 2021; 11():719919. PubMed ID: 34660285
[TBL] [Abstract][Full Text] [Related]
57. Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response.
Cao K; Zhang G; Zhang X; Yang M; Wang Y; He M; Lu J; Liu H
Oncoimmunology; 2021; 10(1):1969075. PubMed ID: 34527431
[TBL] [Abstract][Full Text] [Related]
58. MRI-based multiregional radiomics for predicting lymph nodes status and prognosis in patients with resectable rectal cancer.
Li H; Chen XL; Liu H; Lu T; Li ZL
Front Oncol; 2022; 12():1087882. PubMed ID: 36686763
[TBL] [Abstract][Full Text] [Related]
59. [Prediction of platinum-based chemotherapy sensitivity for epithelial ovarian cancer by multi-sequence MRI-based radiomic nomogram].
Mao MM; Li HM; Shi J; Qiu QS; Feng F
Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):201-208. PubMed ID: 35042289
[No Abstract] [Full Text] [Related]
60. CT radiomics prediction of CXCL9 expression and survival in ovarian cancer.
Gu R; Tan S; Xu Y; Pan D; Wang C; Zhao M; Wang J; Wu L; Zhao S; Wang F; Yang M
J Ovarian Res; 2023 Aug; 16(1):180. PubMed ID: 37644593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
